Myasthenia gravis complement activity is independent of autoantibody titer and disease severity

• Miriam L. Fichtner,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliations Department of Neurology, Yale School of Medicine, New Haven, Connecticut, United States of America, Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America

  https://orcid.org/0000-0002-0107-4103

  ⨯
• Michelle D. Hoarty,

  Roles Formal analysis, Methodology, Validation, Writing – review & editing

  Affiliation UCB Pharma, Cambridge, Massachusetts, United States of America

  ⨯
• Douangsone D. Vadysirisack,

  Roles Methodology, Validation, Writing – review & editing

  Affiliation UCB Pharma, Cambridge, Massachusetts, United States of America

  ⨯
• Bailey Munro-Sheldon,

  Roles Data curation

  Affiliation Department of Neurology, Yale School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Richard J. Nowak,

  Roles Conceptualization, Funding acquisition, Investigation, Resources, Writing – review & editing

  Affiliation Department of Neurology, Yale School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Kevin C. O’Connor

  Roles Conceptualization, Funding acquisition, Investigation, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: kevin.oconnor@yale.edu

  Affiliations Department of Neurology, Yale School of Medicine, New Haven, Connecticut, United States of America, Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America

  ⨯